LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 41 filers reported holding LYRA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $135,821 | -88.1% | 490,861 | +167.1% | 0.00% | -100.0% |
| Q1 2024 | $1,142,881 | +64.5% | 183,743 | +38.6% | 0.00% | +50.0% |
| Q4 2023 | $694,855 | +982.3% | 132,606 | +707.6% | 0.00% | – |
| Q3 2023 | $64,202 | -15.5% | 16,420 | +21.7% | 0.00% | – |
| Q2 2022 | $76,000 | -1.3% | 13,487 | -23.9% | 0.00% | – |
| Q4 2021 | $77,000 | -36.9% | 17,731 | +32.5% | 0.00% | – |
| Q3 2021 | $122,000 | -36.5% | 13,384 | -44.0% | 0.00% | – |
| Q2 2021 | $192,000 | -77.0% | 23,884 | -66.9% | 0.00% | -100.0% |
| Q1 2021 | $835,000 | +224.9% | 72,052 | +220.1% | 0.00% | +100.0% |
| Q4 2020 | $257,000 | +9.8% | 22,510 | +9.2% | 0.00% | 0.0% |
| Q2 2020 | $234,000 | – | 20,621 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
| Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
| PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
| Clearline Capital LP | 119,924 | $482,000 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
| Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
| Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
| Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 500 | $2,000 | 0.00% |